rawfin.tv
Eli Lilly Sues Black Market Sellers of Weight-Loss Drugs
RegulationstocksAI Generated

Eli Lilly Sues Black Market Sellers of Weight-Loss Drugs

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Eli Lilly has filed lawsuits against entities accused of selling unapproved versions of its GLP-1 weight-loss drugs. The pharmaceutical giant aims to protect its intellectual property and market for drugs like retatrutide, which is still in trials.

pharmaceuticalsdrug counterfeitinglegal actionweight-loss drugs

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks